Utility of Polygenic Risk Scoring to Predict Cognitive Impairment as Measured by Preclinical Alzheimer Cognitive Composite Score (PACC)
Gao Q, Daunt P, Gibson A.M, Pither R.J; for the Alzheimer’s Disease Neuroimaging Initiative
J Aging Res & Lifestyle 2022;11:1-8
Polygenic Risk Scoring is an Effective Approach to Predict Those Individuals Most Likely to Decline Cognitively Due to Alzheimer’s Disease
Daunt P, Ballard C.G, Creese B, Davidson G, Hardy J, Oshota O, Pither R, Gibson A.M
J Prev Alz Dis 2021;1(8):78-83
Polygenic risk and hazard scores for Alzheimer’s disease prediction.
Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox N.C, Williams J, GERAD consortium, Hardy J & Escott-Price V.
Ann Clin Transl Neur; 2019, early view first published 18 Feb 2019.
Polygenic risk score analysis of Alzheimer’s Disease in cases without APOE4 or APOE2 alleles.
Escott-Price V, Myers A, Huentelman M, Shoai M & Hardy J.
J Prev Alzheimers Dis. 2019; 6(1); 16-19.
The genetic risk of Alzheimer’s disease beyond APOE ε4: systematic review of Alzheimer’s genetic risk scores.
Stocker H, Möllers T, Perna L & Brenner H.
Transl Psychiatry 2018: 8, 166.
Polygenic risk score analysis of pathologically confirmed Alzheimer disease.
Escott-Price V, Myers A.J, Huentelman M & Hardy J.
Ann Neurol 2017;82(2):311-314
Polygenic score prediction captures nearly all common genetic risk for Alzheimer’s Disease.
Escott-Price V, Shoai M, Pither R, Williams J & Hardy J.
Neurobiol Aging 2017;49:214-217
Common polygenic variation enhances risk prediction for Alzheimer’s Disease.
Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, Badarinarayan N, GERAD/PERADES, IGAP consortia, Morgan K, Passmore P, Holmes C, Powell J, Brayne C, Gill M, Mead S, Goate A, Cruchaga C, Lambert J-C, van Duijn C, Maier W, Ramirez A, Holmans P, Jones L, Hardy J, Seshadri S, Schellenberg G.D, Amouyel P & Williams J.
Brain 2015;138(12):3673-3684